“Gyrolab platform brings key advantages for method development thanks to the high throughput, the flexibility to screen multiple assay configurations in a single run, and the low sample volume.”

Active BiomarkersActive Biomarkers

Active Biomarkers' mission is to translate your unique and precious biological samples into actionable data that will support critical decisions for the development of your therapies.

 

Active Biomarkers has decades of experience in assay development, validation, and the implementation of immunological methods for sample testing. Our experts take great care in understanding the science of your drug and target indication, not forgetting practical constraints of clinical development, to provide you with analytical solution(s) to meet your expectations.

Broad Range of Analytical Services at Active Biomarkers

With a strong track record in 4 major therapeutic areas (immuno-oncology, infectious diseases, inflammatory conditions, and neurological disorders), we routinely analyze a broad range of biological matrices (blood-derived samples, including PBMCs, feces, CSF, skin, bone marrow, etc.), as well as various species, including human samples, non-human primates, and murine models.

Active Biomarkers relies on one of the most comprehensive technological parks in Europe to propose expert solutions for the analysis of:

  • Cell functionality
  • PK/PD
  • Soluble biomarkers
  • Immunophenotyping
  • Anti-Drug Antibodies
  • Assay Development and validation

Gyrolab Platform Applications at Active Biomarkers

Active Biomarkers is equipped with the Gyrolab xPlore platform and offers the development and testing of Gyrolab immunoassays for the following applications:

  • Soluble biomarkers monitoring
  • Pharmacokinetics (specifically for antibody-based therapies)
  • Anti-drug antibodies

Key Advantages of the Gyrolab Microfluidics Technology

Gyrolab platform brings key advantages for method development thanks to the high throughput, the flexibility to screen multiple assay configurations in a single run, and the low sample volume. In our opinion, these features allow us to reconcile method development to short timelines and cost-efficacy.

Gyrolab is a platform of choice for method development (PK, ADA, Soluble Biomarkers) when

  • Multiple reagents should be screened
  • Significant matrix interference is expected
  • Timelines are critical

For more information, visit the Active Biomarkers website